Comparison Innate Pharma (IPHA) with Competitors
Innate Pharma (IPHA) industry is Biotechnology.
Operating Margin
IPHA-690.00%
Industry-2055.25%
Upside+1365.25%
Debt-to-Equity
IPHA-104.00%
Industry28.27%
Upside-132.27%
Free Cash Flow Yield
IPHA-64.27%
Industry-1.75%
Upside-62.53%
P/E
IPHA-1.36
Industry-20.52
Upside+1915.70%
P/S
IPHA18.77
Industry10.01
Upside+87.45%
P/B
IPHA20.10
Industry5.15
Upside+290.54%